Science Explorer Back to mapMap
Discussion
Researcher · Astellas Pharma (Japan) · Japan

Hirotoshi Kakuta

Hirotoshi Kakuta publishes mostly in Molecular Biology, Surgery and Computational Theory and Mathematics, on topics such as Computational Drug Discovery Methods, Plant biochemistry and biosynthesis and Cholesterol and Lipid Metabolism.

OpenAlex
World rank
#4,658,936
of 7,710,434 ranked researchers
Rank in Japan
#138,847
of 383,136
Works
31
Citations
644
Citations per work
20.8
h-index
15
i10-index 18Top 50% in Molecular Biology
Hirotoshi Kakuta

What does Hirotoshi Kakuta research?

Hirotoshi Kakuta's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Medicine (23%), Computer Science (10%).

Life Sciences: 12 works · 39.2% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 32.9% of their workMolecular Biology: 8 works · 25.3% of their workGenetics: 2 works · 7.6% of their workPharmacology, Toxicology and Pharmaceutics: 2 works · 6.3% of their workPharmacology: 2 works · 6.3% of their workEverything else: 9 works · 27.9% of their workHealth Sciences: 7 works · 22.8% of their workMedicine: 7 works · 22.8% of their workSurgery: 5 works · 15.2% of their workCardiology and Cardiovascular Medicine: 2 works · 7.6% of their workPhysical Sciences: 3 works · 10.1% of their workComputer Science: 3 works · 10.1% of their workComputational Theory and Mathematics: 3 works · 10.1% of their workTHEIR WORKHirotoshi Kakuta31works
Life Sciences39%Physical Sciences10%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1032.9%
    2. Pharmacology, Toxicology and Pharmaceutics26.3%
  2. Everything else927.9%
    1. Medicine722.8%
    1. Computer Science310.1%
  1. 1Molecular Biology25% of their works
  2. 2Surgery15% of their works
  3. 3Computational Theory and Mathematics10% of their works
  4. 4Genetics8% of their works
  5. 5Cardiology and Cardiovascular Medicine8% of their works
  6. 6Pharmacology6% of their works

Research topics

Which keywords describe Hirotoshi Kakuta's research?

The keywords of their largest research topics: Metabolism, Pharmacokinetics, Atherosclerosis, Molecular Docking, Virtual Screening, Cholesterol, Isoprenoid Pathway and LXR.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Metabolism122 topics
  2. Pharmacokinetics112 topics
  3. Atherosclerosis102 topics
  4. Molecular Docking81 topic
  5. Virtual Screening81 topic
  6. Cholesterol71 topic
  7. Isoprenoid Pathway71 topic
  8. LXR71 topic
  9. Terpenoid Biosynthesis71 topic
  10. PPARs51 topic
  11. Peroxisome Proliferator-Activated Receptors51 topic
  12. Cholesterol-lowering41 topic
  13. Statins41 topic
  14. ANGPTL331 topic
  15. Crystal Structure31 topic
  16. Cytochrome P45031 topic
  17. G-Protein-Coupled Receptors31 topic
  18. Lipoprotein Lipase31 topic
  19. Pharmacogenetics31 topic

Where does Hirotoshi Kakuta work?

Hirotoshi Kakuta's main affiliation in the publication record is Astellas Pharma (Japan), Japan.

How many publications and citations does Hirotoshi Kakuta have?

OpenAlex counts 31 works and 644 citations for Hirotoshi Kakuta, an h-index of 15, ranking #4,658,936 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hirotoshi Kakuta. Posts are plain text and can be reported.